Agfa HealthCare Signs IMPAX RIS/PACS Agreement with University Medical Center in Maastricht

Agfa HealthCareAgfa HealthCare has signed an agreement with the Maastricht Universitair Medisch Centrum+ (University Medical Center - UMC+) in The Netherlands to install its IMPAX Radiology Information System/Picture Archiving and Communication System (RIS/PACS) and IMPAX for Nuclear Medicine. The solutions will provide workflow support to both the radiology and nuclear medicine departments. The contract was signed on 18 October 2011, and implementation will begin in January 2012.

Supporting the entire patient clinical path
Maastricht UMC+ was created in January 2008 by the merging of the university hospital of Maastricht (azM) and the Faculty of Health, Medicine and Life Sciences of the Maastricht University. In addition to healthcare, UMC+ focuses on education and research activities. It counts over 700 beds, employs over 5000 hospital staff members and educates over 4000 university students. Maastricht UMC+ (the + refers to the integration of medicine and health science in the care chain) treats patients with all types of diseases, from the simple to the very complex.

The agreement between UMC+ and Agfa HealthCare includes the IMPAX RIS/PACS and IMPAX for Nuclear Medicine. These solutions enable users to electronically manage radiology and nuclear medicine operations, end-to-end, from exam ordering to patient registration, through worklist generation and medical reporting, to report distribution. The specialized solutions for radiology and nuclear medicine departments are designed to boost efficiency, improve workflow, increase productivity and help deliver high-quality information to hospital staff, patients and referring physicians.

Solution handles all nuclear medicine exams
The IMPAX for Nuclear Medicine information system comprises an intelligent planning module, which supports complex workflows, and can handle comprehensive resource planning and scheduling across multiple departments. The solution also includes the fully integrated, vendor-neutral Oasis for IMPAX, developed in cooperation with Segami Corp., which makes it possible to work with, analyze and report all nuclear medicine exams, including SPECT and PET, and multi-modality exams, from a single workstation.

The IMPAX solutions offer the extensive functionality, workflow support and system reliability Maastricht UMC+ requires, as well as improved efficiency for the in-vivo diagnostic process and a next-generation roadmap. As Maastricht UMC+ produces more than 199,000 medical images each year; the IMPAX solutions will enable improvements to the efficiency of the medical imaging.

Agfa HealthCare was the only supplier that could meet the specific requirements of UMC+. With its installed base in Europe and around the world, the company is a market leader in RIS/PACS and Regional Health.

Related news articles:

About Agfa
The Agfa-Gevaert Group is one of the world's leading companies in imaging and information technology. Agfa develops manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), for the healthcare sector (Agfa HealthCare), and for specific industrial applications (Agfa Materials). Agfa is headquartered in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries around the globe. The Agfa-Gevaert Group achieved a turnover of 2,948 million euro in 2010.

About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading global provider of diagnostic imaging and healthcare IT solutions. The company has nearly a century of healthcare experience and has been a pioneer on the healthcare IT market since the early 1990's. Today Agfa HealthCare designs, develops and delivers state-of-the-art systems for capturing, managing and processing diagnostic images and clinical/administrative information for hospitals and healthcare facilities, as well as contrast media solutions to enable effective medical imaging results. The company has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2010 were 1,180 million euro.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...